eTheRNA Immunotherapies nv, a clinical-stage company developing vaccines and immunotherapies from its proprietary mRNA TriMix platform, today announced that a consortium has been formed with North American and European partners to develop a novel mRNA vaccine against CoV-2 and preclinical development has started. Chinese partners may be added in the consortium in due course.

eTheRNA Immunotherapies nv

Antwerp

eTheRNA Immunotherapies nv startup from Antwerp, Belgium is ranked 806 out of 2449 worldwide and 8 from the 30 startups in Belgium. See more information and additional rankings on the StartupBlink Global Ecosystem Map